NVO260807C00060000
NVO Aug 7 2026 60.00 Call
optionOPRA
ExpiredAug 7, 2026
0.01USD-95.833%(-0.23)1Vol1,405OI
Loading…
NVO 60 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $0.05 | +0.00% | 1 | 1 |
| Oct 30, 2026 | 6d | $0.04 | +0.00% | 2 | 2 |
| Nov 20, 2026 | 27d | $0.02 | +100.00% | 11 | 6,509 |
| Dec 18, 2026 | 55d | $0.04 | +0.00% | 27 | 19,174 |
| Jan 15, 2027 | 83d | $0.08 | -11.11% | 68 | 24,648 |
| Mar 19, 2027 | 146d | $0.33 | +3.13% | 35 | 2,615 |
| Jun 17, 2027 | 236d | $0.75 | +0.00% | 19 | 4,331 |
| Sep 17, 2027 | 328d | $1.26 | +1.61% | 1 | 371 |
| Dec 17, 2027 | 419d | $1.84 | +3.37% | 45 | 7,558 |
| Jan 21, 2028 | 454d | $2.08 | +4.00% | 8 | 6,314 |
| Jun 16, 2028 | 601d | $2.90 | -4.92% | 65 | 317 |
| Dec 15, 2028 | 783d | $4.15 | +0.73% | 7 | 968 |
| Jan 19, 2029 | 818d | $4.19 | +0.96% | 22 | 109 |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.